Hypertension Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hypertension stocks.

Hypertension Stocks Recent News

Date Stock Title
Nov 21 PFE Optimism over global healthcare sector rises: Jefferies
Nov 21 PFE Major companies that are also popular short-selling stocks
Nov 21 PFE 5 Best Value Stocks With Discounted PEG to Boost Your Portfolio Return
Nov 21 PFE The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair
Nov 21 PFE Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
Nov 21 PFE 2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
Nov 21 PFE EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia
Nov 21 PFE 2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
Nov 20 PFE Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
Nov 20 PFE Pfizer names head of oncology as new R&D chief
Nov 20 PFE Pfizer Announces New Chief Scientific Officer and President, Research & Development
Nov 20 PFE Pfizer names oncology head Chris Boshoff as R&D chief
Nov 20 PFE Pfizer Names New R&D Chief
Nov 20 PFE Pfizer, under pressure to change, names oncology head as new R&D chief
Nov 20 PFE Is It Time to Sell Eli Lilly and Pfizer Stocks?
Nov 20 PFE European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
Nov 20 PFE Flagship, Pfizer alliance yields two more startup deals
Hypertension

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure typically does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.High blood pressure is classified as either primary (essential) high blood pressure or secondary high blood pressure. About 90–95% of cases are primary, defined as high blood pressure due to nonspecific lifestyle and genetic factors. Lifestyle factors that increase the risk include excess salt in the diet, excess body weight, smoking, and alcohol use. The remaining 5–10% of cases are categorized as secondary high blood pressure, defined as high blood pressure due to an identifiable cause, such as chronic kidney disease, narrowing of the kidney arteries, an endocrine disorder, or the use of birth control pills.Blood pressure is expressed by two measurements, the systolic and diastolic pressures, which are the maximum and minimum pressures, respectively. For most adults, normal blood pressure at rest is within the range of 100–130 millimeters mercury (mmHg) systolic and 60–80 mmHg diastolic. For most adults, high blood pressure is present if the resting blood pressure is persistently at or above 130/80 or 140/90 mmHg. Different numbers apply to children. Ambulatory blood pressure monitoring over a 24-hour period appears more accurate than office-based blood pressure measurement.Lifestyle changes and medications can lower blood pressure and decrease the risk of health complications. Lifestyle changes include weight loss, physical exercise, decreased salt intake, reducing alcohol intake, and a healthy diet. If lifestyle changes are not sufficient then blood pressure medications are used. Up to three medications can control blood pressure in 90% of people. The treatment of moderately high arterial blood pressure (defined as >160/100 mmHg) with medications is associated with an improved life expectancy. The effect of treatment of blood pressure between 130/80 mmHg and 160/100 mmHg is less clear, with some reviews finding benefit and others finding unclear benefit. High blood pressure affects between 16 and 37% of the population globally. In 2010 hypertension was believed to have been a factor in 18% of all deaths (9.4 million globally).

Browse All Tags